LGC Clinical Diagnostics, Inc.
EU EUDAMEDUnited States224 registered devices
VerifiedEUDAMED · official EU database
224
Total devices
3
Risk classes
2023
Earliest version
2023
Latest version
Regulatory footprint
Search LGC Clinical Diagnostics, Inc. across other regulatory registries
Recent products (latest 10)
Most recently updated devices in the database
ACCURUN Babesia Molecular Controls Kit
00850041090047
Class B
ACCURUN 31 EBV IgM Positive Control
00816784020161
IVD General
ACCURUN 372 HPV DNA Positive Control Series 600
00816784020642
IVD General
ACCURUN 378 HPV DNA Positive Control Series 5000
00816784020659
IVD General
ACCURUN 342 CT/NG Nucleic Acid Positive Control Series 100
00816784020680
IVD Annex II List B
ACCURUN 381 HPV Type 16 and 18 mRNA Positive Control
00816784020666
IVD General
Multichem ID Rubella IgM Positive Control
00850041090023
IVD Annex II List B
ACCURUN 372 HPV DNA Positive Control Series 400
00816784020635
IVD General
ACCURUN 342 CT/NG Nucleic Acid Positive Control Series 700
00816784020697
IVD Annex II List B
ACCURUN 40 Anti-Measles, Mumps, Rubella, VZV Positive Control Series 5000
00816784020178
IVD Annex II List B
Risk class distribution
Breakdown by risk classification
IVD General20591.5% of total
IVD Annex II List B188.0% of total
Class B10.4% of total
Top authorized representatives
Most common authorized representatives for this manufacturer
About this profile
Explore comprehensive manufacturer profile for LGC Clinical Diagnostics, Inc. through Pure Global AI's free EU medical device database. This company manufactures 224 medical devices registered with EUDAMED across 3 risk classes based in United States.
This page provides detailed insights including recent registrations, risk class distribution (Class B: 1, IVD General: 205, IVD Annex II List B: 18), and complete regulatory information from the official EU EUDAMED medical device database. Pure Global AI offers free access to the European Union's complete medical device registry.